Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Equal-Weight on Steris, Lowers Price Target to $215

Author: Benzinga Newsdesk | December 04, 2023 09:12am
Morgan Stanley analyst Patrick Wood maintains Steris (NYSE:STE) with a Equal-Weight and lowers the price target from $225 to $215.

Posted In: STE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist